TrialBMC infectious diseases2013

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.

Odile Launay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.